B&O Suppositories in Pediatrics

PLEASE NOTE:   Posts made to this forum should not be considered as the expressed opinions of, nor should be considered endorsed by, the Medication Safety Officer’s Society (MSOS) or the Institute for Safe Medication Practices (ISMP). 

Make sure your email is up-to-date
In order to continue to receive updates from MSOS, as well as forum posts and other valuable information as a member of MSOS, please be sure to update your email address with us, whenever it changes. If you need assistance doing so, please send an email to jrufo@ismp.org. 

1 post / 0 new
Log in or register to post comments
Fri, 02/11/2022 - 19:15
#1
Killian Hanley
Killian Hanley's picture
Offline
Last seen: 8 months 1 week ago
Joined: 12/14/2020 - 16:09
B&O Suppositories in Pediatrics

Hello!

We have a request to add Belladonna Alkaloids-Opium (B&O) Suppositories to our formulary. Over 20 years ago we had a patient safety event regarding the use of this suppository in a pediatric patient. Has anyone else experienced serious safety events at their system with the use of B&O suppositories in pediatric patients? For those that have these on formulary, do you have specific protocols/restrictions for use? I've been told ISMP sent out a safety alert involving the use of B&O suppositories in pediatric patients a while ago, however I am unable to find that alert.

Thank you for your help and insight!

Tags: 

Top